VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
-14.02%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$270M
AUM Growth
+$46.4M
Cap. Flow
+$80.5M
Cap. Flow %
29.85%
Top 10 Hldgs %
7.48%
Holding
501
New
128
Increased
202
Reduced
102
Closed
67

Top Buys

1
O icon
Realty Income
O
$925K
2
LLY icon
Eli Lilly
LLY
$843K
3
MRNA icon
Moderna
MRNA
$824K
4
PFE icon
Pfizer
PFE
$803K
5
MRK icon
Merck
MRK
$796K

Top Sells

1
BPMP
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
$1.76M
2
AEM icon
Agnico Eagle Mines
AEM
$1.5M
3
MOS icon
The Mosaic Company
MOS
$716K
4
STR
Sitio Royalties
STR
$468K
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$424K

Sector Composition

1 Real Estate 18.55%
2 Healthcare 17.07%
3 Materials 11.98%
4 Financials 11.43%
5 Energy 8.64%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KDNY
401
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$113K 0.04%
6,441
-4,095
-39% -$71.8K
PTGX icon
402
Protagonist Therapeutics
PTGX
$3.77B
$112K 0.04%
14,129
+8,913
+171% +$70.7K
ARQT icon
403
Arcutis Biotherapeutics
ARQT
$2.06B
$111K 0.04%
5,232
-5,127
-49% -$109K
CGEM icon
404
Cullinan Oncology
CGEM
$413M
$111K 0.04%
8,620
-1,321
-13% -$17K
FHTX icon
405
Foghorn Therapeutics
FHTX
$326M
$111K 0.04%
+8,198
New +$111K
XENE icon
406
Xenon Pharmaceuticals
XENE
$3.02B
$111K 0.04%
3,643
-2,435
-40% -$74.2K
AVIR icon
407
Atea Pharmaceuticals
AVIR
$267M
$110K 0.04%
15,548
-3,785
-20% -$26.8K
CRBU icon
408
Caribou Biosciences
CRBU
$174M
$110K 0.04%
20,215
+10,823
+115% +$58.9K
KOD icon
409
Kodiak Sciences
KOD
$556M
$110K 0.04%
14,453
+12,551
+660% +$95.5K
MORF
410
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$109K 0.04%
5,027
+1,534
+44% +$33.3K
RETA
411
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$109K 0.04%
3,579
-1,785
-33% -$54.4K
IMGO
412
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$109K 0.04%
8,134
-426
-5% -$5.71K
CRSP icon
413
CRISPR Therapeutics
CRSP
$4.99B
$108K 0.04%
1,784
-297
-14% -$18K
DSGN icon
414
Design Therapeutics
DSGN
$367M
$108K 0.04%
+7,716
New +$108K
MDGL icon
415
Madrigal Pharmaceuticals
MDGL
$9.65B
$108K 0.04%
1,504
-635
-30% -$45.6K
MGTX icon
416
MeiraGTx Holdings
MGTX
$619M
$108K 0.04%
14,264
+6,685
+88% +$50.6K
RPTX icon
417
Repare Therapeutics
RPTX
$72.6M
$106K 0.04%
7,586
-305
-4% -$4.26K
NGM
418
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$106K 0.04%
8,263
-519
-6% -$6.66K
ISEE
419
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$106K 0.04%
10,997
+268
+2% +$2.58K
KROS icon
420
Keros Therapeutics
KROS
$633M
$105K 0.04%
3,793
+568
+18% +$15.7K
NKTX icon
421
Nkarta
NKTX
$161M
$105K 0.04%
8,514
-3,612
-30% -$44.5K
CVAC icon
422
CureVac
CVAC
$1.21B
$104K 0.04%
7,676
+3,648
+91% +$49.4K
CYTK icon
423
Cytokinetics
CYTK
$6.34B
$104K 0.04%
2,647
-1,529
-37% -$60.1K
AMRS
424
DELISTED
Amyris Inc.
AMRS
$104K 0.04%
56,359
+26,593
+89% +$49.1K
SRRA
425
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$104K 0.04%
+1,888
New +$104K
15 16
17
18 19